These Numbers Could Change Investor Views For Monster Beverage Corp. (NASDAQ: MNST)

Currently, there are 1.04B common shares owned by the public and among those 752.38M shares have been available to trade.

However, the script later moved the day high at 59.54, down -1.45%. The company’s stock has a 5-day price change of -3.71% and -1.23% over the past three months. MNST shares are trading -1.23% year to date (YTD), with the 12-month market performance up to 8.40% higher. It has a 12-month low price of $47.13 and touched a high of $61.22 over the same period. MNST has an average intraday trading volume of 5.26 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -4.32%, -0.77%, and 1.51% respectively.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Institutional ownership of Monster Beverage Corp. (NASDAQ: MNST) shares accounts for 65.66% of the company’s 1.04B shares outstanding.

It has a market capitalization of $59.21B and a beta (3y monthly) value of 0.71. The stock’s trailing 12-month PE ratio is 36.91, while the earnings-per-share (ttm) stands at $1.54. The company has a PEG of 2.58 and a Quick Ratio of 3.97 with the debt-to-equity ratio at 0.01. Price movements for the stock have been influenced by the stock’s volatility, which stands at 1.85% over the week and 1.66% over the month.

Earnings per share for the fiscal year are expected to increase by 18.40%, and 13.39% over the next financial year. EPS should grow at an annualized rate of 14.30% over the next five years, compared to 11.87% over the past 5-year period.

UBS coverage for the Monster Beverage Corp. (MNST) stock in a research note released on February 29, 2024 offered a Neutral rating with a price target of $63. RBC Capital Mkts was of a view on February 29, 2024 that the stock is Outperform, while Morgan Stanley gave the stock Overweight rating on February 29, 2024, issuing a price target of $63- $68. Jefferies on their part issued Buy rating on February 29, 2024.

Most Popular

Related Posts